Approval · Notice of Compliance 22331 · 2019
ZEJULA: Notice of Compliance 22331
Issued June 27, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22331
- Date
- June 27, 2019
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEJULA | 02489783 | Dormant |
Medicinal ingredients
- NIRAPARIB 100 MG per CAP